Liberator Medical Set to Join the Russell Global, Russell 3000 and
Russell Microcap Indexes on June 27, According to a Preliminary
List Posted on June 13
STUART, FL--(Marketwired -
June 18, 2014) - Liberator Medical Holdings, Inc.
(NYSEMKT: LBMH), a leading provider
of direct-to-consumer medical products and supplies, today
announced it has been selected to join the Russell Global, Russell
3000 and Russell Microcap Indexes when they are reconstituted on
June 27, 2014, according to a preliminary list posted on June 13,
2014, on www.russell.com/indexes.
Russell indexes are widely used by investment managers and
institutional investors for index funds and as benchmarks for
active investment strategies. Approximately $5.2 trillion in assets
are benchmarked to the Russell Indexes. Russell calculates more
than 700,000 benchmarks daily covering approximately 98 percent of
the investable market globally, more than 80 countries and 10,000
securities.
"We are pleased with the selection of Liberator Medical for
inclusion in the Russell Global, Russell 3000 and Russell Microcap
Indexes," said Liberator Medical's CEO, Mark Libratore. "We expect
that these listings will expose Liberator to a wider range of
institutions and investors, which will allow us to broaden our
shareholder base and the market for our shares."
About the Russell Indexes to which Liberator Medical Holdings,
Inc. will be added:
Russell Global Index
Membership in the Russell Global Index, which remains in place
for one year, means automatic inclusion in the appropriate
large-cap, small-cap, all-cap indexes as well as the applicable
style, sector and country indexes. Russell determines membership
for its equity indexes primarily by objective,
market-capitalization rankings and style attributes.
The Russell Global Index, which captures approximately 98% of
investable securities globally, is reconstituted annually and all
sub-indexes are recalibrated simultaneously to accurately measure
current market realities for each market segment. These investment
tools originated from Russell's multi-manager investment business
in the early 1980s when the company saw the need for a more
objective, market-driven set of benchmarks in order to evaluate
outside investment managers.
Russell launched the Russell Global Index in 2007, leveraging
the popular methodology from its U.S. indexes. The broad-market
Russell 3000® Index serves as the U.S. component to the
Russell Global Index.
Russell 3000 Index
Annual reconstitution of Russell's U.S. indexes captures the
4,000 largest U.S. stocks as of the end of May, ranking them by
total market capitalization. Membership in the Russell 3000, which
remains in place for one year, means automatic inclusion in the
large-cap Russell 1000® Index or small-cap Russell 2000® Index
as well as the appropriate growth and value style indexes. Russell
determines membership for its equity indexes primarily by
objective, market-capitalization rankings and style attributes.
Russell Microcap
Membership in the Russell Microcap Index, which remains in place
for one year, means automatic inclusion in the appropriate growth
and value style indexes. Russell determines membership for its
equity indexes primarily by objective, market-capitalization
rankings and style attributes.
About
Russell:
Russell Investments (Russell) is a global asset manager and one
of only a few firms that offers actively managed multi-asset
portfolios and services that include advice, investments and
implementation. Russell stands with institutional investors,
financial advisors and individuals working with their advisors --
using the firm's core capabilities that extend across capital
market insights, manager research, portfolio construction,
portfolio implementation and indexes to help each achieve their
desired investment outcomes.
Russell has more than $259 billion in assets under management
(as of 3/31/2014) and works with over 2,500 institutional clients,
independent distribution partners and individual investors
globally. As a consultant to some of the largest pools of capital
in the world, Russell has $2.4 trillion in assets under advisement
(as of 6/30/2013). It has four decades of experience researching
and selecting investment managers and meets annually with more than
2,200 managers around the world. Russell traded more than $1.6
trillion in 2013 through its implementation services business.
Russell also calculates approximately 700,000 benchmarks daily
covering 98% of the investable market globally, including more than
80 countries and more than 10,000 securities. Approximately $5.2
trillion in assets are benchmarked (as of 12/31/2013) to the
Russell Indexes, which have provided investors with 30 years of
smarter beta.
About Liberator Medical Holdings, Inc.
Liberator Medical Holdings, Inc.'s subsidiary, Liberator Medical
Supply, Inc., established the Liberator brand as a leading national
direct-to-consumer provider of quality medical supplies to
Medicare-eligible seniors. Accredited by The Joint Commission, our
Company's unique combination of marketing, industry expertise and
customer service has demonstrated success over a broad spectrum of
chronic conditions. Liberator is recognized for offering a simple,
reliable way to purchase medical supplies needed on a regular,
ongoing, repeat-order basis, with the convenience of direct billing
to Medicare and private insurance. Liberator's revenue primarily
comes from supplying products to meet the rapidly growing
requirements of general medical supplies, diabetes supplies,
catheters, ostomy supplies and mastectomy fashions . Liberator
communicates with patients and their doctors on a regular basis
regarding prescriptions and supplies. Customers may purchase by
phone, mail or internet, with repeat orders confirmed with the
customer and shipped when needed.
Stay up-to-date with current events by visiting Liberator
Medical's website at www.liberatormedical.com or by joining the
Company's E-Mail Alert List. Join by clicking the following link
www.LBMH-IR.com
Safe Harbor Statement
In this press release and in related comments by our management,
our use of the words "expect," "anticipate," "possible,"
"potential," "target," "believe," "commit," "intend," "continue,"
"may," "would," "could," "should," "project," "projected,"
"positioned" or similar expressions is intended to identify
forward-looking statements that represent our current judgment
about possible future events. We believe these judgments are
reasonable, but these statements are not guarantees of any events
or financial results, and our actual results may differ materially
due to a variety of important factors. Such risks and
uncertainties may include, but are not limited to, regulatory
limitations on the medical industry in general, working capital
constraints, fluctuations in customer demand and commitments,
fluctuation in quarterly results, introduction of new services and
products, commercial acceptance and viability of new services and
products, pricing and competition, reliance upon subcontractors and
vendors, the timing of new technology and product introductions,
and the risk of early obsolescence of our
products. Liberator's most recent annual report on Form 10-K
and quarterly reports on Form 10-Q provide information about these
and other factors, which we may revise or supplement in future
reports filed with the Securities and Exchange Commission.
Contacts:Individual Investor Relations ContactWSR
Communications772-219-7525IR@WSRcommunications.comhttp://wsrcommunications.ir.stockpr.com/liberatormedicalInstitutional
Investor ContactLyn DavisLittlebanc Advisors,
LLC561-948-3005ld@littlebanc.comwww.littlebanc.com
Liberator Medical Holdings, Inc. (AMEX:LBMH)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Liberator Medical Holdings, Inc. (AMEX:LBMH)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024